Lilly Sees More Dealmaking as GLP-1 Wins Expand Market
Eli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
Evaluate the pros and cons of SP 500 ETFs versus index funds for IRAs, focusing on cost, diversification, and tax considerations.
24,931 articlesEli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
Alphabet is famous for growth, not income. A new high-yield option—mandatory convertible preferred shares GOOGM and G...
Debt trends are shifting from policy tool to market risk. This report explains how the U.S. rose to financial promine...
Marvell Technology tumbles on revised AI capex forecasts, intensifying a wider retreat in semiconductor names. Major ...
NuScale Power's stock action sparks questions about small modular reactors and policy timelines. This guide breaks do...
Barclays just boosted its Oracle price target to $240, highlighting a sharper focus on Oracle's cloud expansion and A...
When a company director sells millions after a sharp rally, it stirs worry. But insider activity is nuanced. This gui...
B&G Foods' Q1 2026 earnings set the stage for a cautious yet encouraging year. This guide breaks down the drivers, ri...
Aurora Mobile's Q1 2026 earnings reveal a mix of solid growth and evolving margins. This piece breaks down what the t...
Interpreting the bbcp 2026 earnings transcript reveals how BBCP is growing, where margins are headed, and what to exp...
Nancy Pelosi disclosed a multi-million-dollar stake in AllianceBernstein units, signaling diversification into steady...
Investors want a clear compass for Alphabet stock in the next five years. This article breaks down the growth drivers...